Catani and colleagues provide data on antigenic properties of neuraminidase proteins of pandemic H1N1 and show that antigenic diversity of the neuraminidase from 2009 to 2020 largely falls into two ...

Enrollment and dosing underway by Merck in the Phase 1 Epstein-Barr virus (EBV) vaccine trial ... multispecific antibodies and to initiate an influenza program. ModeX Therapeutics was awarded ...

In this interview, Dr. Christian Schafmeister discusses the structural advantages of Spiroligomer molecules, their ability to ...

From a financial point of view, we realigned our OPKO’s capital structure to be in a strong ... our Epstein-Barr virus multivalent nanoparticle vaccine entered the clinic. This investigational ...

The two phylogenetic groups are color coded and labeled as PG1 and PG2 ... NAI values as fold lower than the serum with the highest normalized NAI for each virus. The highest NAI value against ...

Based on the data presented, the committee agreed that there was a need to change the influenza A/H3N2 virus strains from the 2024-2025 Formula. Recommendations on the strain composition of ...

Six years before the start of the COVID-19 pandemic, an Ebola outbreak in West Africa had people fearing the possibility of a global outbreak. This was the first time many had ever heard of the virus, ...

Mar. 3, 2025 — As highly pathogenic H5N1 avian influenza continues to spread in the U.S., posing serious threats to dairy and poultry farms, both farmers and public health experts need better ...

Avian influenza A(H5N1) is a subtype of influenza virus that infects birds and mammals, including humans in rare instances. Human infections are primarily acquired through direct contact with ...

commonly known as avian influenza or bird flu, raising concerns over its rapid spread and potential risks. According to the reports, for the first time, the country has detected the virus in ...